Form 4: Kenvue Director Larry Merlo Receives Significant Deferred Share Unit Grant

Kenvue Inc. Director Larry J. Merlo was granted 11,914 Deferred Share Units (DSUs) on May 22, 2025, as part of the company's director compensation plan, increasing his total beneficial ownership to over 39,000 DSUs.

Summary

• Larry J. Merlo, a Director of Kenvue Inc. (KVUE), acquired 11,914 Deferred Share Units (DSUs) on May 22, 2025.
• These DSUs were granted under Kenvue's Amended and Restated Deferred Fee Plan for Directors.
• Each DSU represents the right to receive one share of Kenvue's common stock upon the termination of Mr. Merlo's directorship.
• The reported price of the derivative security was $23.5, likely reflecting the underlying common stock value at the time of grant.
• Following this transaction, Mr. Merlo beneficially owns 39,374.526 Deferred Share Units, which includes DSUs acquired as dividend equivalents.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director's continued alignment with the company through equity compensation, which is a standard and expected governance practice. It's not strongly positive as it's not an open market purchase, nor is it negative.

Positives

• The grant of Deferred Share Units aligns the director's interests with long-term shareholder value, as the units are settled in common stock upon termination of directorship.
• The increase in beneficial ownership by a director demonstrates continued commitment to the company.
• The inclusion of dividend equivalents in the DSU balance indicates a comprehensive compensation structure that rewards long-term holding.

Negatives

• The transaction represents a grant of compensation rather than an open market purchase, which might signal stronger conviction.
• The DSUs are not immediately convertible into common stock, meaning the director does not have immediate voting rights or liquidity from these specific units until directorship termination.

Risks

• No specific risks are detailed in this Form 4 filing, as it primarily reports an insider transaction.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely a report of an insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of director compensation, common across publicly traded companies. The grant of Deferred Share Units is a standard practice in corporate governance to align director incentives with long-term shareholder interests, particularly in the consumer health industry where Kenvue operates. It does not provide specific insights into broader industry trends or competitive dynamics.

Comparison to Industry Standards

• The grant of Deferred Share Units (DSUs) as part of director compensation is a common practice among large public companies, including those in the consumer health sector.
• Companies like Procter & Gamble (PG), Johnson & Johnson (JNJ), and Colgate-Palmolive (CL) often utilize similar equity-based compensation plans for their non-employee directors to foster long-term alignment.
• The specific number of units granted and the total beneficial ownership would typically be benchmarked against peer companies' director compensation disclosures, but this document alone does not provide sufficient data for a detailed comparative analysis of compensation levels.
• However, the mechanism of granting DSUs that settle upon termination of service is a widely accepted governance practice.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are mentioned in this Form 4 filing.

Related Party Transactions

• The transaction involves compensation to a director, which is a related party transaction, but it is a standard, disclosed compensation arrangement rather than an unusual dealing.

Stakeholder Impact

• Shareholders: The grant of DSUs to a director aligns the director's long-term interests with shareholders, potentially fostering more stable and value-driven governance.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company, as it is a regulatory filing focused on an individual's beneficial ownership changes.

Key Dates

Keywords

Kenvue Inc., KVUE, Larry J. Merlo, Director Compensation, Deferred Share Units, DSUs, Insider Transaction, SEC Form 4, Equity Grant, Corporate Governance